DK0450991T3 - Anvendelse af phospholipider til behandling af luftvejsobstruktionssygdomme - Google Patents

Anvendelse af phospholipider til behandling af luftvejsobstruktionssygdomme

Info

Publication number
DK0450991T3
DK0450991T3 DK91400304.1T DK91400304T DK0450991T3 DK 0450991 T3 DK0450991 T3 DK 0450991T3 DK 91400304 T DK91400304 T DK 91400304T DK 0450991 T3 DK0450991 T3 DK 0450991T3
Authority
DK
Denmark
Prior art keywords
phospholipids
treatment
airway obstruction
obstruction disorders
disorders
Prior art date
Application number
DK91400304.1T
Other languages
English (en)
Inventor
Sophie Girod-Vaquez
Edith Puchelle
Claude Galabert
Jean-Marie Zahm
Denis Pierrot
Original Assignee
Inst Nat Sant Et De La Rech M
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sant Et De La Rech M, Synthelabo filed Critical Inst Nat Sant Et De La Rech M
Application granted granted Critical
Publication of DK0450991T3 publication Critical patent/DK0450991T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91400304.1T 1990-02-20 1991-02-08 Anvendelse af phospholipider til behandling af luftvejsobstruktionssygdomme DK0450991T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR909001999A FR2658418B1 (fr) 1990-02-20 1990-02-20 Compositions pharmaceutiques a base de phospholipides.

Publications (1)

Publication Number Publication Date
DK0450991T3 true DK0450991T3 (da) 1996-03-04

Family

ID=9393891

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91400304.1T DK0450991T3 (da) 1990-02-20 1991-02-08 Anvendelse af phospholipider til behandling af luftvejsobstruktionssygdomme

Country Status (9)

Country Link
US (1) US5262405A (da)
EP (1) EP0450991B1 (da)
JP (1) JPH04211014A (da)
KR (1) KR910021246A (da)
AT (1) ATE129155T1 (da)
CA (1) CA2036629A1 (da)
DE (1) DE69113848T2 (da)
DK (1) DK0450991T3 (da)
FR (1) FR2658418B1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
AU8285998A (en) * 1997-07-02 1999-01-25 Sdg, Inc. Targeted liposomal constructs for diagnostic and therapeutic uses
IL121322A (en) * 1997-07-16 2002-07-25 Modus Biolog Membranes Ltd Modular pharmacological preparation of the immune system based on fats and its preparation
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
DE19909115A1 (de) * 1999-03-03 2000-09-07 Florian Lang Verwendung von Ceramiden zur Behandlung cystischer Fibrose
DE10012151A1 (de) 2000-03-13 2001-09-27 Gsf Forschungszentrum Umwelt Mittel zur Behandlung von Erkrankungen des Tracheo-Brochialtraktes, insbesondere der COPD
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AU6124601A (en) 2000-05-10 2001-11-20 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
MXPA04005865A (es) 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
CA2368656A1 (en) * 2002-01-21 2003-07-21 Vasogen Ireland Limited Receptor-ligand pairing for anti-inflammatory response
US20050058698A1 (en) * 2002-01-21 2005-03-17 Nolan Yvonne Mairead Pharmaceutically acceptable phosphate-glycerol carrying bodies and uses relating to Parkinson's Disease
AU2004257375A1 (en) * 2003-07-21 2005-01-27 Vasogen Ireland Limited Liposomes containing phosphate glycerol groups for treating acute inflammatory condition
GB0322448D0 (en) * 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
CA2567334A1 (en) * 2004-05-20 2005-12-08 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery
US8028697B2 (en) 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
WO2008011559A2 (en) 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
MX2010010139A (es) 2008-03-17 2011-02-21 Discovery Lab Inc Adaptador de circuito de ventilacion y sistema proximo de suministro en aerosol.
ES2402241T3 (es) 2008-10-22 2013-04-30 Trudell Medical International Sistema de suministro de aerosol modular
US9585930B2 (en) * 2011-03-20 2017-03-07 Trustees Of Boston University Therapeutic agent for emphysema and COPD

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2343481A1 (fr) * 1976-03-11 1977-10-07 Gerlich Norbert Composition destinee a empecher les lesions des membranes biologiques et a regenerer ces membranes une fois qu'elles ont ete endommagees
GB2045612B (en) * 1979-03-27 1983-04-20 Nippon Shoji Kaisha Ltd Pharmaceutical compositions containing phosphatidic acids for the treatment of disorders of consciousness perception and movement
US4725588A (en) * 1979-11-07 1988-02-16 The United States Of America As Represented By The United States Department Of Energy Alkyl phospholipid antihypertensive agents in method of lowering blood pressure
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
IL71051A (en) * 1984-02-23 1988-02-29 Yeda Res & Dev Compositions containing active lipids for the treatment of cystic fibrosis
FR2586587B1 (fr) * 1985-08-30 1987-10-23 Adir Nouveaux surfactants artificiels, leur preparation et les compositions pharmaceutiques qui les contiennent.
GB8522964D0 (en) * 1985-09-17 1985-10-23 Biocompatibles Ltd Aerosol
JPS62152531A (ja) * 1985-12-26 1987-07-07 Dai Ichi Seiyaku Co Ltd リポソ−ムの製造法
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
IT1212137B (it) * 1987-04-08 1989-11-08 Rosanna Lodi Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
US4997761A (en) * 1987-10-06 1991-03-05 Houston Biotechnology Incorporated Phosphatidyl treatment of viral disease
WO1989005152A1 (en) * 1987-12-09 1989-06-15 The Regents Of The University Of California Liposome-encapsulated anti-viral composition and method
CA2037478A1 (en) * 1990-03-05 1991-09-06 Richard Gregory Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator

Also Published As

Publication number Publication date
KR910021246A (ko) 1991-12-20
EP0450991A2 (fr) 1991-10-09
FR2658418A1 (fr) 1991-08-23
EP0450991A3 (en) 1992-12-16
FR2658418B1 (fr) 1994-09-02
JPH04211014A (ja) 1992-08-03
CA2036629A1 (fr) 1991-08-21
DE69113848T2 (de) 1996-04-25
US5262405A (en) 1993-11-16
DE69113848D1 (de) 1995-11-23
EP0450991B1 (fr) 1995-10-18
ATE129155T1 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
DK0450991T3 (da) Anvendelse af phospholipider til behandling af luftvejsobstruktionssygdomme
DK0639577T3 (da) Phosphonooxymethyl- eller methylthiomethylestere af taxanderivater som antitumormidler
FI20011109A (fi) Bis-indolyylisukkiini-imidijohdannaiset ja niiden valmistus
DK2145627T3 (da) Anvendelse af uridin i kombination med cholin til behandling af en humør-lidelse eller en følelsesmæssig lidelse.
DK0842934T3 (da) 5-HT1F agonister
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
NO912630D0 (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler.
NO20004872D0 (no) FremgangsmÕte for Õ stabilisere farmasøytiske sammensetninger ved spesiell anvendelse av en antioksidant
ES2124461T3 (es) Derivados de oxalilamino-benzofurano y de benzotienilo.
NO965516L (no) Sterolderivater anvendt til regulering av meiose
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ATE386742T1 (de) Imidazonaphthyridine
CU23088A3 (es) Compuestos de tetra-hidropiridina.
CY1109496T1 (el) Τρυγικο και φωσφορικο αλας της 3,4-διαμινοπυριδινης, φαρμακευτικες συνθεσεις και χρησεις αυτων
BR9915460A (pt) Método de tratamento de febre hemorrágica virótica
DE69936052D1 (de) N1 modifizierte glycopeptide
ID25478A (id) Agonis 5-ht1f
ES2150418T3 (es) Composiciones farmaceuticas que comprenden calcitonina.
DK0412941T3 (da) Phospholipider til behandling af dissemineret sklerose
SU855640A1 (ru) Стабилизированный источник посто нного напр жени
FI941868A0 (fi) Foerfarande foer hantering av avfallskaerl i anslutning till sopbil och motsvarande anordningar
IT222972Z2 (it) Impianto perfezionato per il trattamento di aria inquinata o simili.